國(guo)(guo)藥(yao)(yao)集(ji)團(tuan)一(yi)(yi)致藥(yao)(yao)業(ye)股(gu)份(fen)有(you)(you)限(xian)公(gong)司(si)(si)(簡(jian)稱國(guo)(guo)藥(yao)(yao)一(yi)(yi)致)國(guo)(guo)藥(yao)(yao)集(ji)團(tuan)一(yi)(yi)致藥(yao)(yao)業(ye)股(gu)份(fen)有(you)(you)限(xian)公(gong)司(si)(si) (簡(jian)稱國(guo)(guo)藥(yao)(yao)一(yi)(yi)致)是中國(guo)(guo)醫(yi)藥(yao)(yao)集(ji)團(tuan)有(you)(you)限(xian)公(gong)司(si)(si)、國(guo)(guo)藥(yao)(yao)控股(gu)股(gu)份(fen)有(you)(you)限(xian)公(gong)司(si)(si)旗下綜合性醫(yi)藥(yao)(yao)上市(shi)(shi)公(gong)司(si)(si)(A股(gu)000028,B股(gu)200028),是國(guo)(guo)藥(yao)(yao)集(ji)團(tuan)全(quan)(quan)國(guo)(guo)醫(yi)藥(yao)(yao)零售整(zheng)合平臺,業(ye)務涵蓋“藥(yao)(yao)品(pin)分銷(xiao)+醫(yi)藥(yao)(yao)物流+醫(yi)藥(yao)(yao)零售+工(gong)業(ye)投(tou)資”全(quan)(quan)產業(ye)鏈條,下屬子公(gong)司(si)(si)達到(dao)110家,員工(gong)30000多人(ren)。承擔著(zhu)中央、省(sheng)(廣東、廣西)、市(shi)(shi)(廣州、深圳、南寧等)藥(yao)(yao)械商品(pin)特種儲備及全(quan)(quan)國(guo)(guo)各地所需搶險救災(zai)藥(yao)(yao)品(pin)調撥和供應任務。
國藥一(yi)致在(zai)(zai)藥品分(fen)銷(xiao)領域,立足于打造“卓(zhuo)越的醫療供(gong)(gong)應(ying)鏈(lian)解決方案及服務(wu)(wu)(wu)提供(gong)(gong)商”,以集成化(hua)、規模(mo)化(hua)的產業(ye)優(you)勢,在(zai)(zai)中國南區形成強大的商業(ye)網(wang)絡(luo)。截止(zhi)目前,公(gong)司(si)(si)在(zai)(zai)廣(guang)州(zhou)、深(shen)圳(zhen)、佛(fo)山(shan)、東莞、等(deng)兩廣(guang)重湛江、梅州(zhou)、惠(hui)州(zhou)、肇慶、江門、韶關、中山(shan)、南寧、柳(liu)州(zhou)要(yao)區域擁有47家子公(gong)司(si)(si),實現(xian)在(zai)(zai)中國南區的深(shen)度滲透。公(gong)司(si)(si)構建起(qi)由區域物(wu)流中心(xin)(xin)、省級物(wu)流中心(xin)(xin)、城市配送(song)中心(xin)(xin)及配送(song)站(zhan)組成的“四位一(yi)體”階梯式物(wu)流配送(song)網(wang)絡(luo),拓展(zhan)多倉運營(ying)、第三方物(wu)流、冷鏈(lian)管(guan)(guan)理等(deng)現(xian)代物(wu)流運作的新模(mo)式,為(wei)客戶及供(gong)(gong)應(ying)商提供(gong)(gong)有效、快捷的藥品配送(song)及物(wu)流增值(zhi)服務(wu)(wu)(wu)。此外,公(gong)司(si)(si)還積極推(tui)動(dong)業(ye)務(wu)(wu)(wu)轉型升(sheng)級,著(zhu)力推(tui)進(jin)全國零(ling)售(shou)終端業(ye)務(wu)(wu)(wu),打造全國零(ling)售(shou)直銷(xiao)商業(ye)平臺(tai)。采用先進(jin)的供(gong)(gong)應(ying)鏈(lian)管(guan)(guan)理方法和(he)現(xian)代技術,開展(zhan)器械業(ye)務(wu)(wu)(wu),拓展(zhan)4D業(ye)務(wu)(wu)(wu),打造SPD核(he)心(xin)(xin)競爭力,攜手醫療機構開展(zhan)供(gong)(gong)應(ying)鏈(lian)管(guan)(guan)理延伸,實現(xian)降費增效。2019年(nian)底,分(fen)銷(xiao)銷(xiao)售(shou)收入超(chao)400億(yi)。
國(guo)藥(yao)(yao)(yao)(yao)(yao)一致在藥(yao)(yao)(yao)(yao)(yao)品零(ling)售(shou)領域(yu),攜手全(quan)球以藥(yao)(yao)(yao)(yao)(yao)店為主(zhu)導的(de)世界醫藥(yao)(yao)(yao)(yao)(yao)保健(jian)企業沃博聯(lian),打(da)造消費者放心(xin)的(de)中(zhong)(zhong)國(guo)醫藥(yao)(yao)(yao)(yao)(yao)健(jian)康(kang)零(ling)售(shou)品牌“國(guo)大藥(yao)(yao)(yao)(yao)(yao)房”。目前(qian),已在全(quan)國(guo)21個省(sheng)、自治(zhi)區、直轄市(shi)建(jian)立了27家(jia)區域(yu)連鎖(suo)公(gong)司,覆蓋全(quan)國(guo)75各地級(ji)城市(shi),擁有超(chao)過5000家(jia)零(ling)售(shou)藥(yao)(yao)(yao)(yao)(yao)店。六年來(lai)穩居(ju)中(zhong)(zhong)國(guo)醫藥(yao)(yao)(yao)(yao)(yao)零(ling)售(shou)行業首位(wei)。依托先(xian)進的(de)管理能力、有效快捷(jie)的(de)采(cai)購體(ti)系、嚴格的(de)質量管控(kong)、精細的(de)門店管理、貼(tie)心(xin)的(de)慢病服務、有效的(de)物流體(ti)系、全(quan)國(guo)ERP平臺等一系列優勢,局(ju)涵蓋中(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)、西藥(yao)(yao)(yao)(yao)(yao)、中(zhong)(zhong)醫、西醫、康(kang)復理療(liao)與各類(lei)醫療(liao)相關資源的(de)零(ling)售(shou)診療(liao)門店,創新應用“互聯(lian)網+”技術,攜手各地政(zheng)府開展在線社區健(jian)康(kang)建(jian)設,保障(zhang)人民健(jian)康(kang)需求。2019年,國(guo)大藥(yao)(yao)(yao)(yao)(yao)房銷售(shou)收入(ru)超(chao)120億元。
國藥(yao)一致(zhi)工(gong)業(ye)(ye)投資戰略主要參股工(gong)業(ye)(ye)企業(ye)(ye)國藥(yao)致(zhi)君(jun)深(shen)(shen)圳制(zhi)藥(yao)有(you)限(xian)公(gong)司、國藥(yao)致(zhi)君(jun)深(shen)(shen)圳坪山(shan)制(zhi)藥(yao)有(you)限(xian)公(gong)司、深(shen)(shen)圳致(zhi)君(jun)醫(yi)藥(yao)貿易有(you)限(xian)公(gong)司、深(shen)(shen)圳萬(wan)樂藥(yao)業(ye)(ye)有(you)限(xian)公(gong)司,覆蓋抗感染、呼吸(xi)系統用(yong)藥(yao)、保健品、中(zhong)成藥(yao)及抗腫(zhong)瘤藥(yao)等領域(yu)的研(yan)發、生(sheng)產(chan)及銷售。2019年,工(gong)業(ye)(ye)投資板塊銷售額超40億元。
未來,國(guo)藥(yao)一致將繼續秉承“關愛(ai)生命 呵護健康(kang)”的理(li)念,立足(zu)中(zhong)國(guo)醫藥(yao)健康(kang)產(chan)業發(fa)展機遇,轉型創(chuang)新(xin),深度發(fa)揮(hui)分銷和(he)零售資源協(xie)同效應,推進批零一體(ti)戰略和(he)國(guo)際化(hua)戰略,以(yi)科技創(chuang)新(xin)推進公司數字化(hua)轉型,向著國(guo)際化(hua)醫藥(yao)健康(kang)服務(wu)平臺和(he)更(geng)高規模目標邁進!